Pilar de la Rocha Mur/LinkedIn
Jul 11, 2026, 18:53
Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
Pilar de la Rocha Mur, Vice-President, Head of EMEA at BeOne Medicines, shared on LinkedIn:
”Trust is still the real currency in clinical research.
That was the theme that ran through the BeOne Medicines investigator meeting at EHA 2026 in Stockholm, and it’s one I keep coming back to.
Last night in Stockholm, I had the privilege of being in a room with some of Europe‘s leading hematology investigators.
Around 100 experts with one shared purpose: making clinical research better for patients.
What stayed with me the most was the quality of the conversation.
Here are my two takeaways from an evening that reminded me why this work matters.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 11, 2026, 18:25First Pathogenic Deep-Intronic SERPINC1 Variant Identified in Hereditary Antithrombin Deficiency – JTH
-
Jul 11, 2026, 18:12Dianne E. van der Wal: A Thought-Provoking Discussion on Immunothrombosis at ISTH 2026
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026
-
Jul 11, 2026, 15:22Cécile Denis: A Unique Opportunity for Emerging Hemostasis Leaders
-
Jul 11, 2026, 15:03Dino Mehic: Paris Welcomes the Global Hemostasis Community at ISTH 2026
-
Jul 11, 2026, 14:55Carsten Deppermann: An Inspiring Perspective on Scientific Discovery
-
Jul 11, 2026, 14:47Isabella Presch: Arrived in Amazing Paris For ISTH 2026
-
Jul 11, 2026, 14:12Riten Kumar: The Opening Day Experience at ISTH 2026
-
Jul 11, 2026, 13:44Mary Cushman: A Decade After the RPTH Journal Launch at ISTH 2026